Background In metastatic breast cancer, hormone and/or human epidermal growth factor
receptor 2 (HER2)–targeted therapy decision-making is still largely based on tissue …

Today, clinical evaluation of tumor heterogeneity is an emergent issue to improve clinical
oncology. In particular, intra-tumor heterogeneity (ITH) is closely related to cancer …

Brain metastasis is a major cause of cancer mortality, but its molecular mechanisms are
severely understudied. In addition, little is known regarding the role of m 6 A reader YTHDF3 …

Investigating epidemiology of metastatic colon and rectal cancer is challenging, because
cancer registries seldom record metastatic sites. We used a population based approach to …

Importance Population-based estimates of the incidence and prognosis of brain metastases
at diagnosis of breast cancer are lacking. Objective To characterize the incidence …

Purpose A number of recent publications have proposed that a family of image-derived
indices, called texture features, can predict clinical outcome in patients with cancer …

Because of improvements in the treatment of patients with metastatic breast cancer, the
development of brain metastases (BM) has become a major limitation of life expectancy and …

Many cancer types metastasize to bone. This propensity may be a product of genetic traits of
the primary tumour in some cancers. Upon arrival, cancer cells establish interactions with …

Though the incidence of several cancers in Western societies is regulated wisely, some
cancers such as breast, lung, and colorectal cancer are currently rising in many low-and …

Cancer statistics in 2018 highlight an 8.6 million incidence in female cancers, and 4.2 million
cancer deaths globally. Moreover, breast cancer is the most frequent malignancy in females …